Abstract |
|
Authors | Louis Terriou, Sarah Bonnet, Houria Debarri, Hélène Demarquette, Franck Morschhauser |
Journal | Bulletin du cancer
(Bull Cancer)
2013 Jul-Aug
Vol. 100
Issue 7-8
Pg. 775-9
ISSN: 1769-6917 [Electronic] France |
Vernacular Title | Brentuximab vedotin: nouvelle option thérapeutique dans la prise en charge des lymphomes CD30+ |
PMID | 23831822
(Publication Type: Journal Article, Review)
|
Chemical References |
- Immunoconjugates
- Ki-1 Antigen
- Brentuximab Vedotin
|
Topics |
- Brentuximab Vedotin
- Clinical Trials, Phase I as Topic
- Clinical Trials, Phase II as Topic
- Hodgkin Disease
(drug therapy, immunology)
- Humans
- Immunoconjugates
(therapeutic use)
- Ki-1 Antigen
- Lymphoma, Large-Cell, Anaplastic
(drug therapy, immunology)
|